Washington · 2025–26 Regular Sessions · Bill
SB 5916: Nonopioid drugs for pain
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 5916 is a bill introduced in the Washington Senate on December 17, 2025. According to its official title, it concerns: Concerning nonopioid drugs for the treatment of pain. Primary sponsor: Paul Harris (R). It lists 2 additional sponsors. Most recent recorded action (March 12, 2026): By resolution, returned to Senate Rules Committee for third reading.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official title
AN ACT Relating to nonopioid drugs for the treatment of pain;
Nonpartisan staff bill reports (analyses) are available on the official bill page.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Paul Harris | Primary sponsor | Republican | Senate | 17 |
| Mike Chapman | Co-sponsor | Democratic | Senate | 24 |
| Rebecca Saldaña | Co-sponsor | Democratic | Senate | 37 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- By resolution, returned to Senate Rules Committee for third reading.
- First reading, referred to Health Care & Wellness.
- 1st substitute bill substituted.
- Floor amendment(s) adopted.
- Rules suspended. Placed on Third Reading.
- Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
- Placed on second reading by Rules Committee.
- Passed to Rules Committee for second reading.
- HLTC - Majority; 1st substitute bill be substituted, do pass.
- First reading, referred to Health & Long-Term Care.
- Prefiled for introduction.